Latest news
Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTTudriqev: US FDA Approves Replimune's Skin Cancer Drug After Rejecting It Twice - Health and MeHealth and Me · Fri, 07 Aug 2026 12:34:03 GMTTwice-Rejected Advanced Melanoma Treatment Wins FDA Committee Vote - Oncology News CentralOncology News Central · Fri, 31 Jul 2026 07:00:00 GMT